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a b s t r a c t
Most alphaviruses are mosquito-borne and exhibit a broad host range, infecting many different
vertebrates including birds, rodents, equids, and humans. Occasionally, alphaviruses can spill over into
the human population and cause disease characterized by debilitating arthralgia or fatal encephalitis.
Recently, a unique alphavirus, Eilat virus (EILV), was described that readily infects mosquito but not
vertebrate cell lines. Here, we investigated the ability of EILV to induce superinfection exclusion. Prior
infection of C7/10 (Aedes albopictus) cells with EILV induced homologous and heterologous interference,
reducing the virus titers of heterologous superinfecting viruses (SINV, VEEV, EEEV, WEEV, and CHIKV) by
10–10,000 fold and delaying replication kinetics by 12–48 h. Similar to in vitro infection, prior in vivo
EILV infection of Aedes aegyptimosquitoes delayed dissemination of chikungunya virus for 3 days. This is
the ﬁrst evidence of heterologous interference induced by a mosquito-speciﬁc alphavirus in vitro and
in vivo.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The genus Alphavirus in the family Togaviridae is comprised of
small, spherical, enveloped viruses with genomes consisting of a
single strand, positive-sense RNA approximately 11–12 kb in
length (Grifﬁn, 2007). The genus consists of 31 recognized species
classiﬁed into ten complexes based on antigenic and/or genetic
similarities (Arrigo et al., 2010; Forrester et al., 2012; Nasar et al.,
2012; Powers et al., 2001). The two aquatic alphavirus complexes
[southern elephant seal virus and salmon pancreas disease virus]
are not known to utilize arthropods in their transmission cycles,
whereas all the remaining complexes [Barmah Forest, Ndumu,
Middelburg, Semliki Forest, Venezuelan (VEE), eastern (EEE),
western equine encephalitis (WEE) and Trocara] consist of arbo-
viruses that almost exclusively utilize mosquitoes as insect vectors
(Grifﬁn, 2007; La Linn et al., 2001; Villoing et al., 2000; Weaver
et al., 2012; Weston et al., 1999). Mosquito-borne alphaviruses can
infect mosquito species encompassing at least eight genera (Aedes,
Culex, Anopheles, Culiseta, Haemagogus, Mansonia, Verrallina, and
Psorophora) and many vertebrate taxa including equids, birds,
amphibians, reptiles, rodents, pigs, as well as human and non-
human primates (Grifﬁn, 2007; Karabatsos, 1985; Jupp et al., 1981;
Webb et al., 2008). This ability to infect both mosquitoes and
vertebrates enables maintenance of alphaviruses in nature in
enzootic cycles with occasional spillover into the human popula-
tion. Old World viruses such as chikungunya (CHIKV), o’nyong-
nyong (ONNV), Sindbis (SINV), and Ross River (RRV) are rarely fatal
and cause clinical disease characterized by rash and debilitating
arthralgia. In contrast, New World viruses such as western
(WEEV), eastern (EEEV), and Venezuelan equine encephalitis
(VEEV) viruses cause fatal encephalitis (Grifﬁn, 2007). Currently,
there are no licensed vaccines or effective antiviral treatments
available to prevent or treat human infection by alphaviruses.
Recently, a host-restricted alphavirus, Eilat virus (EILV), was
described that is serologically distinct from other alphaviruses but
phylogenetically groups within the mosquito-borne clade as a sister
to the WEE complex (Nasar et al., 2012). In contrast to all other
mosquito-borne alphaviruses, EILV is unable to infect or replicate in
vertebrate cells but can readily replicate to high titers (4108 PFU/
mL) in mosquito cells (Nasar et al., 2012). The EILV vertebrate host
range restriction is present at the attachment/entry as well as
genomic RNA replication levels (Nasar et al., 2015). EILV is the ﬁrst
mosquito-speciﬁc alphavirus described, and represents a new
complex within the genus (Nasar et al., 2015).
Superinfection exclusion or homologous interference is a phe-
nomenon where prior infection with a virus reduces or prevents a
subsequent infection with a closely related virus. This phenomenon
was ﬁrst described with two closely related genotypes of tobacco
mosaic virus, where plants previously infected with common-mosaic
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virus could not be subsequently infected with the yellow-mosaic
tobacco virus (McKinney, 1926, 1929). This phenomenon has been
successfully developed as a tool to prevent or reduce the loss of crops
and is termed “cross protection” (Ziebell and Carr, 2010). Following
its discovery, superinfection exclusion was also demonstrated with
animal and mosquito-only viruses including alphaviruses (Bolling et
al., 2012; Bratt and Rubin, 1968a; Claus et al., 2007; Geib et al., 2003;
Hobson-Peters et al., 2013; Kenney et al., 2014; Kent et al., 2010;
Laskus et al., 2001; Lee et al., 2005; Steck and Rubin, 1966a; Tscherne
et al., 2007; Walters et al., 2004; Whitaker-Dowling et al., 1983; Zou
et al., 2009). The available in vitro data demonstrate that a prior
alphavirus infection can reduce replication of a superinfecting
homologous or heterologous virus (Adams and Brown, 1985; Eaton,
1979; Karpf et al., 1997; Lennette and Koprowski, 1946; Renz and
Brown, 1976; Stollar and Shenk, 1973; Zebovitz and Brown, 1968).
These studies raise the intriguing possibility of utilizing alphaviruses
as transmission control measures to limit or eliminate human and/or
animal infection. However, all of the viruses within the mosquito-
borne clade are capable of replication in both vertebrates and insects,
and in addition many can cause severe disease in animals and
humans (Grifﬁn, 2007). Consequently, the use of these viruses is
unsuitable for transmission control measures. In contrast, the host-
restricted and therefore vertebrate apathogenic EILV is potentially
ideal for this application. Here, we investigated the ability EILV to
induce homologous and heterologous superinfection exclusion.
Results
Homologous interference in C7/10 cells
To assess superinfection with homologous and heterologous
viruses in vitro in C7/10 cells, an optimal multiplicity of infection
(MOI) to establish EILV infection was investigated (Fig. 1). Infection of
C7/10 cells at an MOI of 10 plaque-forming units (PFU)/mL with EILV-
eRFP established infection in 490% of cells within 24 h and was
subsequently utilized for superinfection experiments (Fig. 2). To
investigate exclusion of homologous virus, C7/10 cells were infected
with EILV at an MOI of 10, followed by infection with EILV-eRFP at an
identical MOI (Fig. 3). Almost all of the mock-infected cells expressed
eRFP 24 h post-infection (hpi), whereas little or no expression was
observed in EILV-infected cells up to 72 h post-superinfection,
indicating exclusion of homologous virus (Fig. 3).
Heterologous interference in C7/10 cells
To investigate heterologous interference, C7/10 cells were
infected with EILV at an MOI of 10 to establish initial infection
and at 24 hpi cells were superinfected with SINV-eGFP or VEEV-
TC83-eGFP at an MOI of 1 or 0.1 (Fig. 1). Heterologous interference
was monitored by eGFP expression via ﬂuorescent microscopy.
Most of the mock-infected cells expressed eGFP 24 hpi following
SINV-eGFP or VEEV-TC83-eGFP infection, whereas minimal eGFP
expression was detected in EILV-infected cells at either MOI
(Fig. 4). At 72 h post-superinfection, increased eGFP expression
was observed irrespective of the MOI or virus (Fig. 4).
To further explore heterologous interference, superinfection
was also monitored via replication kinetics. Following mock or
EILV infection, C7/10 cells were superinfected with SINV or VEEV
strain TC83 at an MOI of 1 or 0.1 (Fig. 1). EILV-infected cells
displayed a statistically signiﬁcant reduction in superinfecting
SINV or VEEV-TC83 titers at early time points [6, 12, and 24 (both
viruses) and 48 (SINV only)] at both MOIs, with p-values o0.02
for all time points (Fig. 5). SINV and VEEV-TC83 titers were
reduced by 100 to 10,000-fold between 6 and 24 hpi (Fig. 5).
In addition to the reduction in virus titers, the replication kinetics
of superinfecting viruses were delayed by 12–48 h regardless of
virus or MOI (Fig. 5). These data corroborated results obtained via
ﬂuorescent microscopy, and suggested that prior EILV infection
was able to induce heterologous interference, reducing super-
infecting virus production and delaying replication kinetics.
Next, we investigated the heterologous interference of alpha-
viruses associated with severe human disease: EEEV strain FL93,
VEEV subtype IC strain 3908, WEEV strain McMillan, and CHIKV
strain JKT. C7/10 cells were infected with EILV at an MOI of 10
followed by superinfection with heterologous viruses at an MOI of
0.1 (Fig. 1). Similar to results obtained with superinfection of SINV
and VEEV-TC83, all heterologous viruses displayed a reduction in
virus production and delayed replication kinetics at early time
points in EILV-infected cells (Fig. 6). Virus titers of superinfecting
viruses were reduced by 10 to 1,000-fold at 6, 12, 24 and 48 hpi
with p-values o0.04 for all time points (Fig. 6). VEEV and WEEV
displayed the greatest reduction of 1,000-fold at 24 and 48 hpi,
respectively (Fig. 6). Replication kinetics of all superinfecting
viruses were also delayed by at least 12–48 h (Fig. 6). WEEV was
the only virus that replicated to peak virus titers similar to those in
mock-infected cells, whereas the peak titers of other three viruses
were reduced by 10 to 52-fold compared to their respective
mock-infected counterparts (Fig. 6).
Fig. 1. Experimental design to investigate homologous and heterologous interference by Eilat virus in vitro.
Fig. 2. EILV-eRFP infection of C7/10 cells at an MOI of 10 PFU/cell. Phase contrast
and ﬂuorescent ﬁeld micrographs were taken at 24 hpi.
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Heterologous interference in Aedes aegypti mosquitoes
To investigate heterologous interference in mosquitoes, A.
aegypti mosquitoes were utilized as they are susceptible to both
EILV and CHIKV infection (Karabatsos, 1985; Nasar et al., 2014).
Cohorts of A. aegypti were injected via the intrathoracic (IT) route
with 1 mL of EILV at a titer of 107 PFU/mL to establish initial
infection (Figs. 1 and 7A). Five mosquitoes were assayed 7 days
Fig. 3. EILV-induced homologous interference in C7/10 mosquito cells determined via eRFP expression. Phase contrast and ﬂuorescent photographs were taken at 24 and
72 h post-superinfection.
Fig. 4. EILV-induced heterologous interference in C7/10 cells, (A) SINV-eGFP and (B) VEEV-TC83-eGFP. Heterologous virus replication was measured via ﬂuorescent
microscopy. Phase contrast and ﬂuorescent micrographs were taken at 24 and 72 h post-superinfection.
F. Nasar et al. / Virology 484 (2015) 51–58 53
post-injection to conﬁrm EILV infection via plaque assays. As
expected, all mosquitoes were infected with an average titer of
2.9 log10 PFU/mosquito (Fig. 7B). At 7 days post-EILV injection,
mosquitoes were provided bloodmeals containing CHIKV at
105 PFU/mL. CHIKV infection was monitored via cytopathic effects
(CPE) and plaque assays on Vero cells. Mosquito body infection
rates were lower in EILV-infected group than in the mock-infected
cohort at 3 and 5 days post-superinfection: 70% vs. 95% and 75% vs.
85%, respectively (Fig. 7C). However, by days 7 post-superinfection,
the body superinfection rate was identical in both groups (75%)
(Fig. 7C). EILV infection delayed CHIKV dissemination from the
midgut to the legs and wings for 3 days post-superinfection,
whereas the dissemination rates were higher or identical at
5 and 7 days post-superinfection, respectively, as compared to
the mock-infected group (Fig. 7C). Lastly, CHIKV titers in both
bodies and legs/wings were similar at all time points in both EILV-
and mock-infected groups (Fig. 7C).
Disscussion
Homologous and heterologous interference has been investi-
gated previously with alphaviruses in mosquito and vertebrate cell
lines. Aedes albopictus cells persistently infected with SINV are
Fig. 5. EILV-induced heterologous interference in C7/10 cells, (A) SINV and (B) VEEV-TC83. Heterologous virus titers were determined via plaque assay. Each time point
represents average of triplicate infections. Bars indicate standard deviations for each time point. p-values o0.02 are indicated with *.
Fig. 6. EILV-induced heterologous interference in C7/10 cells, (A) EEEV-NA, (B) VEEV-IC, (C) WEEV-McM, and (D) CHIKV-JKT. Heterologous virus titers were determined via
plaque assay. Each time point represents average of triplicate infections. Bars indicate standard deviations for each time point. p-values o0.04 are indicated with *.
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resistant to subsequent superinfection with homologous virus
(Adams and Brown, 1985; Renz and Brown, 1976; Stollar and
Shenk, 1973). Similarly, superinfection of A. albopictus cells persis-
tently infected with CHIKV or SINV reduces virus titers of super-
infecting heterologous viruses (UNAV, SFV, SINV, CHIKV, AURAV,
and RRV) by 10 to 1,000-fold (Eaton, 1979; Karpf et al., 1997). In
addition, studies with chicken embryo cells infected with West
Nile, yellow fever or VEEV viruses demonstrated 25 to 10,000-
fold reduction in superinfecting VEEV or EEEV titers (Lennette and
Koprowski, 1946; Zebovitz and Brown, 1968).
We investigated whether similar interference can be induced
with a mosquito-only alphavirus, EILV. EILV infection almost
completely prevented subsequent infection with EILV-eRFP, where
only 2–5 cells expressing eRFP could be observed per 105 cells.
In addition, EILV infection reduced superinfecting virus production
by 10 to 10,000-fold and delayed replication kinetics of hetero-
logous superinfecting viruses (SINV, VEEV, EEEV, CHIKV, WEEV) by
12–48 h. These results demonstrate that EILV infection in vitro
induces homologous and heterologous interference at levels
comparable to those shown in previous studies with other
alphaviruses.
Limited studies have investigated homologous and heterologous
arbovirus interference in vivo (Altman, 1963; Beaty et al., 1983,
1985; Borucki et al., 1999; Chamberlain and Sudia, 1957; Davey et
al., 1979; Lam and Marshall, 1968a, 1968b; Pesko and Mores, 2009;
Rozeboom and Kassira, 1969; Sabin, 1952; Sundin and Beaty, 1988).
Elegant studies utilizing temperature sensitive Semliki Forest and La
Crosse virus mutants demonstrated homologous interference by
either inhibiting or reducing viral production of superinfecting virus
by 10–500-fold (Beaty et al., 1983, 1985; Davey et al., 1979;
Rozeboom and Kassira, 1969; Sundin and Beaty, 1988). Investiga-
tions into heterologous interference have yielded similar results
with reduction in replication, reduction and/or prevention of
dissemination, or reduced transmission of superinfecting virus
(Altman, 1963; Borucki et al., 1999; Chamberlain and Sudia, 1957;
Lam and Marshall, 1968a, 1968b; Pesko and Mores, 2009; Sabin,
1952). However, the investigation of heterologous interference with
mosquito-speciﬁc Culex ﬂavivirus (CxFV) has yielded contradictory
results; Culex pipiens naturally infected with CxFV have reduced
WNV viral loads and dissemination rates 7 dpi after oral super-
infection with WNV (Bolling et al., 2012), whereas Culex quinque-
fasciatus intrathoracically infected with CxFV display no difference
in vector competence for WNV than their mock-infected counter-
parts (Kent et al., 2010). Here, we report the ﬁrst evidence of
heterologous interference with EILV virus in mosquitoes. Prior EILV
infection of A. aegypti reduced superinfection rates and delayed
CHIKV dissemination from the midgut for 3 days post-infection.
Further studies are required to investigate this effect with other
pathogenic alphaviruses.
The investigation of EILV-mediated heterologous interference
in vitro with SINV and VEEV clones with and without eGFP yielded
some differences at 72 h post-superinfection. The expression of
eGFP was limited at 72 h and was more pronounced with SINV-
eGFP superinfection, whereas the clones without eGFP cassette
were able to achieve similar virus titers as their mock counter-
parts (Figs. 4 and 5). There are several possible explanations for
the incongruent results. First, competition for viral and/or host
factors needed for viral replication, transcription, and translation
may reduce eGFP expression. The eGFP clones contain an addi-
tional subgenomic promoter that likely competes for limited viral
and/or host factors involved in the transcription and translation of
two subgenomic RNAs. Additionally, the superinfected cells con-
tain two viruses with three subgenomic promoters, which may
also compete for limited host factors for transcription and transla-
tion; 2) the expression of SINV subgenomic RNAs may require high
levels of transcription and translation. Limited data suggest that
SINV virion formation is less efﬁcient than that of VEEV, requiring
5–8 fold higher levels of viral RNAs and structural proteins
(Volkova et al., 2006). The competition of host and viral factors
may prevent and/or delay the levels of transcription and transla-
tion required for expression of subgenomic RNAs thus reducing
eGFP expression.
Fig. 7. EILV-induced heterologous interference in A. aegypti mosquitoes. (A) Outline of experimental design; (B) EILV infection in mosquitoes 7 dpi and CHIKV blood meal
titer, and; (C) CHIKV-SL07 superinfection of mosquitoes 3, 5, and 7 dpi. Bold indicates p-value¼0.003.
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EILV-mediated interference was not observed beyond 5 days
post-CHIKV superinfection in mosquitoes. There are several pos-
sible explanations for this lack of sustained heterologous inter-
ference; 1) decreased EILV replication with time leads to reduced
interference thus enabling CHIKV replication; 2) EILV and CHIKV
may have different cell tropisms in vivo and consequently limited
coinfection of cells; 3) the intrinsic ability of EILV to induce
interference mechanism/s may be lower as a consequence of
adaptation to a single (mosquito) host; and 4) CHIKV may be able
to overcome EILV-mediated interference mechanism/s. EILV titers
at 7 days-post-injection were 100-fold lower than those
reported for CHIKV in A. aegypti, suggesting that a decrease in
EILV replication may play a role in reduced heterologous inter-
ference (Tsetsarkin et al., 2006). However, these hypotheses
require further investigation.
Interference mechanisms that prevent or reduce infection of
superinfecting viruses have been shown to act on various stages of
the virus replication cycle: downregulation of expression of
cellular receptors for viruses, reduction/prevention of entry,
reduced endocytic vesicle formation, decreased internalization of
bound ligands/receptors, competition for coated pits, prevention
of disassembly by encapsidation of incoming viral genomes, poor
acidiﬁcation of early endosomes, prevention of fusion with the
host membrane, inhibition of nucleocapsid uncoating, inhibition of
viral replication, competition for host factors; and induction of
RNA silencing by the primary virus, resulting in sequence-speciﬁc
degradation of superinfecting virus (Bratt and Rubin, 1968a,
1968b; Lee et al., 2005; Lohmann et al., 2003; Lu et al., 1998;
Michel et al., 2005; Simon et al., 1990; Steck and Rubin, 1966a,
1966b; Walters et al., 2004). Limited studies have examined
interference mechanisms induced by alphaviruses. The mechan-
isms identiﬁed by these studies include reduced binding, inefﬁ-
cient penetration, inhibition of nucleocapsid uncoating, and post-
translational inhibition of replication complexes of superinfecting
homologous virus (Adams and Brown, 1985; Renz and Brown,
1976; Singh et al., 1997). The latter interference mechanism was
suggested to involve cleavage of the superinfecting nsP123 poly-
protein, an essential component of the negative strand replicase,
by nsP2 of the initially infecting virus, thus reducing negative
strand synthesis. Although several studies have produced indirect
evidence supporting this hypothesis; however, formal proof is
lacking (Ehrengruber and Goldin, 2007; Sawicki et al., 2006). Our
in vitro results with heterologous superinfecting viruses do not
support this hypothesis. The SINV nsP2/3 cleavage site is identical
to that of EILV and its nsP1/2 site differs only by one amino acid;
consequently there should be greater exclusion of SINV than of
WEEV, whose nsP cleavage sites display greater sequence diver-
gence (Fig. 5) (Nasar et al., 2012). Superinfection with SINV and
WEEV resulted in almost identical levels of reduction in virus
production and delays in replication kinetics (Figs. 5 and 6). In fact,
a much greater inhibition effect was measured at 48 h post-
superinfection with WEEV (1000-fold) than with SINV (10-
fold) (Figs. 5 and 6). These data indicate premature cleavage of
superinfecting heterologous virus negative strand replicase prob-
ably plays little or no role in preventing replication of super-
infecting heterologous viruses.
The superinfection interference we observed is likely due to, in
part, to competition for host factors and replication sites, as well as
RNA interference (RNAi). The latter is an important antiviral
defense in mosquitoes in response to alphavirus infection invol-
ving multiple RNAi pathways (Adelman et al., 2013; Brackney
et al., 2010; Campbell et al., 2008; Cirimotich et al., 2009; Keene
et al., 2004; Khoo et al., 2010; Morazzani et al., 2012; Myles et al.,
2008; Schnettler et al., 2013; Vodovar et al., 2012). However, the
roles of RNAi and other mechanisms in superinfection exclusion
require further investigation.
Heterologous interference could theoretically be utilized to
control transmission of pathogenic arboviruses. However, verte-
brate-pathogenic, mosquito-borne alphaviruses are obviously
unsuitable as a potential biological control measure. Host
restricted viruses, such as EILV and CxFV, which do not infect
vertebrates, could be developed to safely control arbovirus trans-
mission. However, the available data demonstrate that the intrin-
sic ability of both EILV and CxFV to interfere with pathogenic
arboviruses in vivo is modest and requires improvement. One
promising strategy to increase interference is to genetically engi-
neer EILV and other viruses to deliver siRNA targeting pathogenic
viruses (Gaines et al., 1996; Olson et al., 1996; Powers et al., 1996).
Infection of C6/36 cells with a SINV clone encoding anti-sense
sequences of dengue virus rendered them resistant to infection
with dengue-2 (DENV-2) (Gaines et al., 1996). A. aegypti mosqui-
toes infected with the same SINV clone are unable to support
DENV-2 replication in salivary glands, and consequently are
unable to transmit DENV (Olson et al., 1996). Similarly, SINV clones
engineered to target the S segment of La Crosse virus reduced
virus replication both in vitro and in vivo (Powers et al., 1996).
Taken together, these data suggest that either the intrinsic EILV
properties and/or genetically engineered clones of EILV have
potential to be utilized as transmission reducing approaches to
control and/or prevent alphavirus disease.
Materials and methods
Viruses and cells
SINV strain Eg339, EEEV strain FL93-939, VEEV subtype IC
strain 3908, WEEV strain McMillan, CHIKV strain JKT, and CHIKV
strain SL07 were obtained from World Reference Center for
Emerging Viruses and Arboviruses at the University of Texas
Medical Branch. SINV-eGFP strain Tr-339, VEEV-TC83, and VEEV-
TC83-eGFP were obtained from internal collections.
Vero cells were obtained from the American Type Culture
Collection (Bethesda, MD), and both BHK and C7/10 cells were
obtained from internal collections. Cell lines were propagated at
37 1C (Vero and BHK) or 28 1C (C7/10) with 5% CO2 in DMEM
containing 10% (V/V) fetal bovine serum (FBS), sodium pyruvate
(1 mM), penicillin (100 U/mL), and streptomycin (100 μg/mL).
C7/10 cell media was additionally supplemented with 1% (V/V)
tryptose phosphate broth (Sigma).
Superinfection exclusion in C7/10 cells
To determine an optimal MOI for homologous and heterologous
interference experiments, C7/10 cells were counted with a hemo-
cytometer in bright and ﬂuorescent ﬁelds to determine the
number and percentage of EILV-eRFP infected cells. Similar experi-
ments were performed to estimate number of cells superinfected
with homologous virus.
Ca. 20–30% conﬂuent C7/10 monolayers seeded overnight were
infected with EILV or EILV-eRFP at an MOI of 10 PFU/cell, or mock-
infected; 24 h post-EILV or mock infection, monolayers were
superinfected with homologous (MOI of 10) or heterologous
viruses at an MOI of 1 or 0.1 PFU/cell (Fig. 1). Superinfection
exclusion was monitored via ﬂuorescent microscopy and replica-
tion kinetics. For ﬂuorescent microscopy, infections were per-
formed in 12-well plates and phase-contrast and ﬂuorescent
ﬁeld photographs were taken at 24 and 72 h post-superinfection.
Replication kinetics were performed in triplicate in T-25 cm2
cell culture ﬂasks. Following superinfection with heterologous
virus for 1 h at 28 1C, monolayers were rinsed ﬁve times with
room temperature (RT) DMEM to remove unbound virus, and 5 mL
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of growth medium were added to each ﬂask. Aliquots of 0.5 mL
were taken immediately afterward as “time 0” samples and
replaced with 0.5 mL of fresh medium. Flasks were incubated at
28 1C, and further samples were taken at 6, 12, 24, 48, and 72 hpi.
All samples were ﬂash frozen in an ethanol/dry ice bath and stored
at 80 1C.
Plaque assay
All virus samples, except EILV, were titrated on 90% conﬂuent
BHK (in vitro experiments) or Vero (in vivo experiment) cell
monolayers seeded overnight in six-well plates. Cell monolayers
were overlaid with 3 mL of 1 DMEM containing 1% FBS (V/V),
penicillin (100 U/mL), streptomycin (100 μg/mL) and 0.2% agarose
(V/V) (Lonza Inc., Allendale, NJ). Cells were incubated at 37 1C with
5% CO2 for 2 (BHK) and 3 (Vero) days for plaque development. Eilat
virus titrations were performed on 80% conﬂuent C7/10 cell
monolayers seeded overnight in six-well plates. Following infec-
tion, cells were overlaid with 3 mL of a 1:1 mixture of 2%
tragacanth and 2 MEM containing 5% FBS, 2% tryptose phos-
phate broth solution (V/V), penicillin (200 U/mL), and streptomy-
cin (200 μg/mL). Cells were incubated at 28 1C with 5% CO2 for
3 days for plaque development. Following development of plaques,
the overlays were removed and monolayers were ﬁxed with 10%
formaldehyde in PBS for 30 min. Cells were stained with 2% crystal
violet in 30% methanol for 5 min at RT; excess stain was removed
and plaques were counted.
Superinfection exclusion in mosquitoes
A. aegypti eggs from colonies at UTMB were hatched and reared
using standard methods (Rosen and Gubler, 1974). Cohorts of 200
adult females collected 5–6 days after emergence from the pupal
stage were cold-anesthetized and inoculated via the IT route with
PBS or with 1 mL of EILV at 107 PFU/mL. Mosquitoes were given
10% sucrose and held for an extrinsic incubation period of 7 days at
28 1C. Following incubation, mosquitoes were fed an artiﬁcial meal
consisting of deﬁbrinated sheep blood (Colorado Serum Company,
Denver, CO) and CHIKV-SL07 at a ﬁnal concentration of 105 PFU/
mL. Mosquitoes were allowed to feed for 1 h, and following
feeding mosquitoes were cold-anesthetized and sorted. Fully
engorged mosquitoes at or higher than stage 3 were retained for
the study (Pilitt and Jones, 1972). Mosquitoes were provided 10%
sucrose and 20 individuals per cohort were sampled 3, 5, 7 days
post-CHIKV infection. Mosquitoes were cold-anesthetized, and
bodies and legs/wings were removed and placed in 0.5 mL of
1 DMEM containing 20% FBS (V/V), penicillin (200 U/mL),
streptomycin (200 μg/mL), and 5 mg/mL amphotericin B. Samples
were triturated using a Mixer Mill 300 (Retsch, Newtown, PA),
centrifuged at 18,000 g for 5 min and supernatants from each
sample were analyzed for CPE on Vero cells. Positive samples from
days 3, 5, and 7 post-CHIKV infection were titrated via plaque
assay on Vero cells. Number of samples tittered: all positive
samples (3 day post-CHIKV infection), N¼10 (5 day post-CHIKV
infection), and N¼5 (7 day post-CHIKV infection).
Statistics
RStudio (Version 0.97, RStudio, Boston, MA) running R (Version
3.0.1, R Development Core Team, Vienna, Austria) software was used
for statistical analysis. Signiﬁcant differences in mean titers during
superinfection were determined using two-way ANOVA for all viruses
followed by a Tukey Test. Two-tailed Fisher exact test was performed
to determine signiﬁcant differences in dissemination rates.
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